Lanean...
Updating the landscape of direct-to-consumer pharmacogenomic testing
Pharmacogenomics has identified important drug–gene interactions that affect the safety and efficacy of medications. Direct-to-consumer genetic testing, when first introduced, included some pharmacogenomic-related genes. The current landscape of pharmacogenomic direct-to-consumer testing is reviewed...
Gorde:
| Argitaratua izan da: | Pharmgenomics Pers Med |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572950/ https://ncbi.nlm.nih.gov/pubmed/28860839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S140461 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|